HOME
ABOUT
RELIVER
PIPELINE
JOBS
UPDATES
More
ReLiver: Morphocell's engineered tissue simply explained in its future potential to treat liver disease.
Using advanced tissue engineering, we’re developing the world’s first effective treatments for the most dire liver diseases
Morphocell Technologies Join Forces with CQDM and the Stem Cell Network to Advance Regenerative Medicine for Pediatric Urea Cycle Disorders
BioSurfaces and Morphocell Technologies Announce Collaboration to Explore Therapeutic Applications of Bio-Spun™ Material
Morphocell Technologies Appoints Dr. Paul K. Wotton to the Board of Directors
Renowned Biotech Leader Dr. Vincent Ling Joins Morphocell Technologies as Chief Business Officer
Morphocell Technologies appoints Marc Courtois to Board of Directors
Morphocell Technologies appoints Didier Leconte as an independent member of its Board of Directors
Morphocell Technologies welcomes Patrick Bedford as Vice President of Regulatory Affairs
Morphocell Technologies Announces Completion of US$40 Million Series A Financing to Transform the Treatment of Liver Disease
